NEW YORK, Sept. 22, 2017 -- Safirstein Metcalf LLP updates investors about the shareholder class action filed against Equifax Inc. (“Equifax” or the “Company”) (NYSE:EFX). The class action is on behalf of investors who purchased shares between February 25, 2016 and September 7, 2017, inclusive (the “Class Period”).
If you purchased or acquired Equifax common stock during the class period, or if you have held Equifax shares since February 2016 and continue to hold shares, and would like more information about the shareholder action, please contact Safirstein Metcalf LLP at 1-800-221-0015, or email [email protected]
If you wish to serve as lead plaintiff, you must move the Court no later than November 13, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
According to the Complaint, throughout the Class Period, Equifax issued materially false and/or misleading statements, and/or failed to disclose, that the Company failed to maintain proper security systems, controls and monitoring systems in place to protect its data systems and detect security breaches. On September 7, 2017, Equifax announced that its systems were hacked in a cybersecurity incident that may have affected about 143 million U.S. consumers. According to the Company, hackers accessed names, Social Security numbers, birth dates, addresses and driver’s license numbers. Hackers also accessed credit card numbers for about 209,000 consumers.
Following the release of this information, the Company’s shares fell more than 13%, or $19.49 per share to close at $123.23 on September 8, 2017. Since the announcement of the cyberattack, Equifax has lost more than $5 billion in market cap.
About Safirstein Metcalf LLP
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP
Peter Safirstein, Esq.
1250 Broadway
27th Floor
New York, NY 10001
1-800-221-0015


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Italy Fines Apple €98.6 Million Over App Store Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 



